CVS CVS Health Corp.
CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Company profile
Ticker
CVS
Exchange
Website
CEO
Larry J. Merlo
Employees
Incorporated in
Location
Fiscal year end
Sector
Industry (SEC)
Former names
CVS Caremark Corp, CVS Corp, Cvs/caremark Corp, Melville Corp
SEC CIK
Corporate docs
IRS number
50494040
CVS stock data
()
Calendar
6 Nov 19
11 Dec 19
31 Dec 19
News
Company financial data Financial data
| Quarter (USD) | Sep 19 | Jun 19 | Mar 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | 64.81B | 63.43B | 61.65B | 54.42B | |
| Net income | 1.53B | 1.94B | 1.42B | -419M | |
| Diluted EPS | 1.17 | 1.49 | 1.09 | -0.37 | |
| Net profit margin | 2.36% | 3.05% | 2.31% | -0.77% | |
| Operating income | 2.93B | 3.33B | 2.69B | 824M | |
| Net change in cash | -870M | 167M | 1.84B | -37.53B | |
| Cash on hand | 5.19B | 6.06B | 5.9B | 4.06B | |
| Cost of revenue | 40.44B | 38.97B | 37.25B | 40.56B |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 194.58B | 184.79B | 177.55B | 153.29B | |
| Net income | -594M | 6.62B | 5.32B | 5.24B | |
| Diluted EPS | -0.57 | 6.44 | 4.9 | 4.63 | |
| Net profit margin | -0.31% | 3.58% | 2.99% | 3.42% | |
| Operating income | 4.02B | 9.54B | 10.39B | 9.48B | |
| Net change in cash | 2.36B | -1.68B | 912M | -22M | |
| Cash on hand | 4.06B | 1.7B | 3.37B | 2.46B | |
| Cost of revenue | 156.45B | 156.22B | 148.67B | 126.76B |
Financial data from CVS Health earnings reports
Financial report summary
?
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accomplished, BePurchased, Coventry, DollarValue, extinguishment, forfeiture, HIF, highest, Insider, Larry, modernization, NM, nonrestricted, ofPublicly, parent, preceding, President, proximity, recoverable, released, repay, SharesPurchased, size, star, suspended, tender, thatMay, transformation, Twp, unamortized, Waterford
Removed:
advance, declining, evaluate, introducing, receiving
Financial reports
10-Q
2019 Q3
Quarterly report
6 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
1 May 19
10-K
2018 FY
Annual report
28 Feb 19
10-Q
2018 Q3
Quarterly report
6 Nov 18
10-Q
2018 Q2
Quarterly report
8 Aug 18
10-Q
2018 Q1
Quarterly report
2 May 18
10-K
2017 FY
Annual report
14 Feb 18
10-Q
2017 Q3
Quarterly report
6 Nov 17
10-Q
2017 Q2
Quarterly report
8 Aug 17
Current reports
8-K
CVS Health Reports Third Quarter Results
6 Nov 19
8-K
Other Events
5 Sep 19
8-K
Departure of Directors or Certain Officers
29 Aug 19
8-K
CVS Health Corporation Announces Pricing of Maximum Tender Offers
22 Aug 19
8-K
CVS Health Corporation Announces Final Results of Any and All Tender Offers and Confirms the Maximum Amounts for Maximum Tender Offers
19 Aug 19
8-K
CVS Health Corporation Announces Expiration and Results of Any and All Tender Offers
15 Aug 19
8-K
CVS Health Corporation Announces Pricing of Any and All Tender Offers
14 Aug 19
8-K
Other Events
12 Aug 19
8-K
CVS Health Corporation Announces Cash Tender Offers
8 Aug 19
8-K
2019 FY
Other Events
8 Aug 19
Registration and prospectus
424B2
Prospectus for primary offering
12 Aug 19
FWP
Free writing prospectus
8 Aug 19
424B3
Prospectus supplement
8 Aug 19
S-8
Registration of securities for employees
1 Mar 19
S-8
Registration of securities for employees
30 Nov 18
POS AM
Prospectus update (post-effective amendment)
30 Nov 18
425
Business combination disclosure
26 Nov 18
425
Business combination disclosure
20 Nov 18
425
Business combination disclosure
6 Nov 18
425
Business combination disclosure
6 Nov 18
Proxies
DEFA14A
Additional proxy soliciting materials
7 May 19
DEFA14A
Additional proxy soliciting materials
5 Apr 19
DEF 14A
Definitive proxy
5 Apr 19
DEF 14A
Definitive proxy
24 Apr 18
DEFA14A
Additional proxy soliciting materials
24 Apr 18
PRE 14A
Preliminary proxy
12 Apr 18
PX14A6G
Letter to shareholders
3 May 17
DEFA14A
Additional proxy soliciting materials
1 May 17
DEF 14A
Definitive proxy
31 Mar 17
DEFA14A
Additional proxy soliciting materials
31 Mar 17
Other
UPLOAD
Letter from SEC
27 Aug 19
CORRESP
Correspondence with SEC
20 Aug 19
UPLOAD
Letter from SEC
8 Aug 19
CORRESP
Correspondence with SEC
10 Jul 19
EFFECT
Notice of effectiveness
11 Dec 18
UPLOAD
Letter from SEC
1 Aug 18
CORRESP
Correspondence with SEC
19 Jul 18
UPLOAD
Letter from SEC
16 Jul 18
CORRESP
Correspondence with SEC
9 Feb 18
EFFECT
Notice of effectiveness
9 Feb 18
Ownership
SC 13G/A
CVS HEALTH Corp
11 Feb 19
SC 13G/A
CVS HEALTH Corp
11 Feb 19
SC 13G/A
CVS HEALTH Corp
8 Feb 18
SC 13G/A
CVS HEALTH Corp
29 Jan 18
SC 13G/A
CVS HEALTH Corp
9 Feb 17
SC 13G/A
CVS HEALTH Corp
23 Jan 17
SC 13G/A
CVS HEALTH Corp
12 Feb 16
SC 13G/A
CVS HEALTH Corp
10 Feb 16
SC 13G/A
CVS HEALTH Corp
10 Feb 16
SC 13G/A
CVS HEALTH Corp
13 Feb 15